Category Archives: St. Jude Defibrillators
First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL
The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...
Pennsylvania Health System Proposes Comprehensive Fracking Study
A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.
Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage
A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...
Research Suggest Fracking Chemicals Can Pollute Aquifers
A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...
Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings
Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.
Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR
Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.
First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January
The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...
Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million
Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...
Heart Rhythm Journal Rejects St. Jude Request to Retract Riata Lead Study
The journal Heart Rhythm will not retract a study published last month that linked St. Jude Medical’s Riata and Riata ST defibrillator leads to 22 deaths that were the result of high-voltage failures of the leads. St. Jude, which had … Continue reading
Medtronic Claims Analysis Confirms Recent Findings on St. Jude Riata Defibrillator Lead Death Rates
Medtronic Inc. is backing findings of a study that raised serious safety concerns about Riata and Riata ST defibrillator leads made by rival, St. Jude Medical Inc. The study, conducted by Dr. Robert Hauser and published in the journal Heart … Continue reading
St. Jude Claims Study on Alleged Riata Lead Deaths is Biased and Inaccurate
St. Jude Medical wants the Heart Rhythm Journal to retract a study published last month that linked its Riata line of internal defibrillator leads to more 20 deaths. In a statement issued by St. Jude on Friday, the company asserted … Continue reading
St. Jude to Halt Sales of QuickSite and QuickFlex Defibrillator Leads Over Safety Concerns
St. Jude Medical Inc., a leading medical devices manufacturer, has stopped marketing two of its cardiac defibrillator leads after incidents of them malfunctioning were reported. Business Week reports St. Jude has stopped sales of its QuickSite and QuickFlex wires due … Continue reading
Study Links St. Jude Riata Defibrillator Lead Defects to 22 Deaths
People implanted with St. Jude’s now-recalled Riata defibrillator lead wires face risks from electrical shorts caused by a number of problems with the wires, according to a new study. The study, which was presented Monday at the American College of … Continue reading
Weak Device Monitoring Blamed for Tardy St. Jude Riata Lead Recall
Many of the problems caused by St. Jude Medical Riata implanted defibrillator leads could have been prevented if more initiative had been taken to monitor its safety track record in patients. According to a Bloomberg report citing a recent study … Continue reading
St. Jude Riata Defibrillator Leads Recalled for Serious Injury, Death Risk
An urgent recall has been issued for St. Jude Medical Inc.’s Riata and Riata ST. Silicone Defibrillator Leads. According to a notice posted on its website, the U.S. Food & Drug Administration (FDA) has deemed the St. Jude Riata defibrillator … Continue reading
St. Jude Settles Defibrillator Kickback Charges
The United States Department of Justice just announced that St. Jude Medical Inc. of St. Paul, Minnesota, has agreed to pay the United States $16 million to resolve allegations that it used post-market studies and a registry to pay kickbacks … Continue reading
FDA Targets Defective Defibrillators
A new Food & Drug Administration (FDA) report on < "http://www.yourlawyer.com/practice_areas/defective_medical_devices">external defibrillators finds that the devices malfunction far too often, and that such malfunctions can prove fatal. Yesterday, the agency announced that it has launched an initiative aimed at facilitating … Continue reading
